Syphilis Immunoassay Diagnostics Market By Product Type, By Technology, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Analyzers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Kits and reagents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country

CHAPTER 5: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 CLIA
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 ELISA
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country

CHAPTER 6: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Blood Banks
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Diagnostic Labs
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Hospitals
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country

CHAPTER 7: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Technology
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Technology
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Technology
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Technology
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Technology
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Technology
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Technology
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Technology
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Technology
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Technology
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Technology
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Technology
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Technology
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Technology
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Technology
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Technology
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Technology
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Technology
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Technology
7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 BioRad Laboratories Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Danaher Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 BECTON DICKINSON & COMPANY
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 , F. Hoffmann-La Roche AG
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Siemens Healthineers AG
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Diasorin S. P. A
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Abbott Laboratories
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Fujirebio
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 , BioMerieux SA
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Shenzhen New Industries Biomedical Engineering Co. Ltd
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Syphilis Immunoassay Diagnostics Market,' the syphilis immunoassay diagnostics market was valued at $315.5 million in 2021, and is estimated to reach $446.0 million by 2031, growing at a CAGR of 3.5% from 2022 to 2031.

Syphilis is a sexually transmitted infection caused by Treponema pallidum. The disease is mainly diagnosed through clinical findings and serologic testing. However, no single serologic test of syphilis is sufficient. Hence, the serologic diagnosis of syphilis requires the detection of two types of antibodies (nontreponemal antibodies and treponemal antibodies).

The rise in socioeconomic factors such as sexually transmitted diseases, increase in awareness about syphilis immunoassay diagnostics, and surge in government expenditure on healthcare drives the growth of the Syphilis Immunoassay Diagnostics Market Size. Moreover, Syphilis Immunoassay Diagnostics Market Trends such as increase in rates of fatal syphilis infections, surge in testing facilities, the widespread use of technology in testing, and the availability of on-the-spot testing further helps in the growth of the Syphilis Immunoassay Diagnostics Industry. However, a lack of knowledge among individuals in emerging economies is expected to hinder the growth of this market.

The global Syphilis Immunoassay Diagnostics Market Share is segmented based on product type, technology, end user, and region. On the basis of product type, the market is divided into analyzers and kits & reagents. Depending on technology, the market is classified into CLIA and ELISA. As per end user, the market is classified into blood banks, diagnostic labs, and hospitals. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of product type, the market is classified into analyzers and kits & reagents. The kits and reagents segment is projected to exhibit the largest Syphilis Immunoassay Diagnostics Market Share during the forecast period, owing to increase in the prevalence of syphilis among the population, surge in healthcare expenditure, and rise in adoption of syphilis diagnostic products for screening.

On the basis of technology, the market is classified into CLIA and ELISA. The CLIA segment is anticipated to have largest Syphilis Immunoassay Diagnostics Market Size, owing to upsurge in number of patients of sexually transmitted diseases, increase in the number of diagnosis procedures of syphilis, growth in Syphilis Immunoassay Diagnostics Industry and rise in number of research and development activities for syphilis testing. Moreover, the surge in testing facilities, the widespread use of technology in testing, and the availability of on-the-spot testing helps in the growth of the market.

On the basis of end user, the market is classified into blood banks, diagnostic labs, and hospitals. The blood banks segment is anticipated to grow at the highest rate, owing to increase in the number of biotechnology companies and rise in research activities of cell therapy. Moreover, the rise in number of pharmaceutical companies contributes in the growth of the market.

On the basis of region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). In 2021, North America was the dominant region and is expected to remain dominant during the Syphilis Immunoassay Diagnostics Market Forecast period, owing to the high prevalence rate of syphilis, increase in the number of market players, and surge in testing facilities in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of sexually transmitted diseases and the increasing number of strategies and trends adopted by the market players.

KEY FINDINGS OF THE STUDY

By product type, the kits and reagents segment accounted for major share of the Syphilis Immunoassay Diagnostics Market Analysis in 2021.

By technology, the CLIA segment is anticipated to grow with the highest CAGR during the forecast period.

By end user, the blood banks segment is anticipated to grow with the highest CAGR during the forecast period.

By region, North America occupied major share of the syphilis immunoassay diagnostics market in 2021.

Companies Mentioned

• Biorad Laboratories Inc.
• Danaher Corporation
• Becton Dickinson & Company
• , F. Hoffmann-La Roche AG
• Siemens Healthineers AG
• Diasorin S.P.A
• Abbott Laboratories
• Fujirebio
• , Biomerieux SA
• Shenzhen New Industries Biomedical Engineering Co. Ltd

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.